Rahul Jandial has received a $1.35 million grant from the Department of Defense Breast Cancer Research Program to support his laboratory research into leptomeningeal disease.
The DoD’s Breast Cancer Research Program awarded the Breakthrough award grant to Jandial, an associate professor in City of Hope’s Division of Neurosurgery.
Also known as carcinomatous meningitis, LMD is characterized by the spreading of tumor cells to the lining of the brain and spinal cord. Despite its discovery nearly 150 years ago, it remains the most ominous diagnosis a patient can receive — yet with the fewest treatment options.
